Cardiff Oncology Inc (CRDF) returns
Cardiff Oncology returns over 10 years
$1,000 invested in Cardiff Oncology ten years ago was worth $3.25 at the close on October 30, 2026, with dividends reinvested: an average return of -43.6% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -26.5% | — | $735.21 | -0.9% |
| 3 months | +4.5% | — | $1,045 | +2.1% |
| Year to date | -68.3% | — | $316.58 | +11.7% |
| 1 year | -60.1% | — | $398.92 | +12.4% |
| 3 years | -19.9% | -7.1% | $801.44 | +88.5% |
| 5 years | -84.8% | -31.4% | $151.55 | +76.0% |
| 10 years | -99.7% | -43.6% | $3.25 | +316.6% |
Cardiff Oncology return by calendar year
| Year | CRDF | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -68.3% | +11.7% | -80.0% |
| 2025 | -35.3% | +17.7% | -53.0% |
| 2024 | +193.2% | +24.9% | +168.4% |
| 2023 | +5.7% | +26.2% | -20.5% |
| 2022 | -76.7% | -18.2% | -58.5% |
| 2021 | -66.6% | +28.7% | -95.3% |
| 2020 | +1,351% | +18.4% | +1,332% |
| 2019 | -60.7% | +31.2% | -91.9% |
| 2018 | -85.8% | -4.6% | -81.2% |
| 2017 | -85.4% | +21.7% | -107.1% |
| 2016 | -61.1% | +12.0% | -73.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CRDF financials
No forecast, no recommendation. This page describes Cardiff Oncology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.